SCHEMBL7708891

SCHEMBL7708891

COc1ccc(-c2cc(N)n3nc(-c4ccno4)nc3c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
NPC1 O15118 3/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 3/20 0.49
RAB9A P51151 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
PKM P14618 1/20 0.49
CDK5 Q00535 1/20 0.49
CDK5R1 Q15078 1/20 0.49
ADORA2A P29274 7/20 0.40
ADORA3 P0DMS8 1/20 0.38
ADORA1 P30542 1/20 0.38
MAPT P10636 1/20 0.38
CHEK1 O14757 1/20 0.38
EGFR P00533 1/20 0.38
NTRK1 P04629 1/20 0.38
RET P07949 1/20 0.38
ROS1 P08922 1/20 0.38
KIT P10721 1/20 0.38
PIM1 P11309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708864 0.88 TDO2 (0.41) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL7709236 0.87 ALDH1A1 (0.48) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL7709121 0.87 CSNK1D (0.42) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL7709024 0.86 NPC1 (0.41) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL7711697 0.86 ADORA2A (0.35) KDM4ENPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL7708391 0.84 ADORA2A (0.45) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL7709161 0.82 ADORA2A (0.53) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL7709135 0.82 ADORA2A (0.58) HPGDSMN1; SMN2ADORA2AKMT2A
SCHEMBL7708813 0.81 NPC1 (0.37) KDM4ENPC1ALDH1A1RAB9AADORA2A
SCHEMBL7708784 0.80 SMN1; SMN2 (0.54) KDM4ENPC1ALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed